Articles
“There’s a lot we don’t know about lung cancer screening,” according to Denise Aberle, MD, who spoke at the recent American Association for Cancer Research International Conference on Frontiers in Cancer Prevention Research. Read More ›
This second issue of Conquering the Cancer Care Continuum™ focuses on the serious nature of the problems associated with access to care. Whether it be access to cancer screening, diagnosis, treatment, or follow-up care, it is an issue that remains unresolved. Read More ›
The state of healthcare in 2014 necessitates that patients play an active role in the management of their health. But who, among Americans, has access to healthcare? This access occurs when an individual is fortunate enough to have available the timely use of services, so he or she can achieve the best health possible. Read More ›
When I joined the faculty of the McWhorter School of Pharmacy (MSOP) at Samford University in Birmingham, Alabama, in July of 2008, I was excited to discover a corporate spirit and passion for involvement with underserved populations that were similar to that of my own. Read More ›
I am very excited to announce our Third Annual Conquering the Cancer Care Continuum newsletter series. These publications will continue to address highly relevant topics in oncology management. The first issue focuses on current good manufacturing practice (cGMP) and includes articles written by a clinical oncology pharmacist, an oncology nurse practitioner, and a regulatory lawyer. Read More ›
As a nurse practitioner and a researcher whose focus is on supportive care in cancer, many of my patients and their caregivers look to me for answers to their questions regarding over-the-counter (OTC) supplements and prescription drugs used to treat various disorders. Oftentimes, patients seek my opinion concerning appropriate OTC and prescription drugs for treating such conditions as peripheral neuropathy. Read More ›
R is a 43-year-old man with a primary hepatocellular carcinoma. He was diagnosed 6 months ago with metastatic disease and today has been told that there are no remaining conventional treatment options available for the management of his cancer. To look at this patient is to see a young man who seems to be otherwise healthy, a man who continues to work full time, to travel, and to be an active husband and father. Read More ›
Confusion over the rules governing drug compounding has been an issue for many years. However, concerns about the safety and quality of compounded sterile products (CSPs), spurred by an outbreak of fungal meningitis infections that occurred in October 2012, have led to a fundamental change in the regulatory framework. Read More ›
The use of generic docetaxel instead of branded docetaxel appears to be associated with a significantly higher event rate of neutropenia, as well as increased healthcare costs, during the 6 months following drug initiation, according to a US Oncology Research study that compared resource utilization and costs. Read More ›